Healthcare provider profile · identity verified

Geetha Conjeevaram, M.D.

Internal Medicine · ATHENS, OH · NPI 1316940364

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	832	237
Lisinopril	Lisinopril	533	130
Amlodipine Besylate	Amlodipine Besylate	473	125
Levothyroxine Sodium	Levothyroxine Sodium	422	105
Losartan Potassium	Losartan Potassium	341	92
Metformin Hcl	Metformin Hcl	254	69
Simvastatin	Simvastatin	217	56
Metoprolol Succinate	Metoprolol Succinate	204	50
Famotidine	Famotidine	193	51
Gabapentin	Gabapentin	192	54
Sertraline Hcl	Sertraline Hcl	170	44
Metoprolol Tartrate	Metoprolol Tartrate	164	50
Tramadol Hcl	Tramadol Hcl	155	32
Pantoprazole Sodium	Pantoprazole Sodium	147	41
Alendronate Sodium	Alendronate Sodium	141	33
Glimepiride	Glimepiride	135	39
Trazodone Hcl	Trazodone Hcl	135	45
Albuterol Sulfate Hfa	Albuterol Sulfate	123	41
Hydrochlorothiazide	Hydrochlorothiazide	120	35
Furosemide	Furosemide	119	26
Lorazepam	Lorazepam	112	21
Omeprazole	Omeprazole	107	33
Olmesartan Medoxomil	Olmesartan Medoxomil	106	25
Eliquis	Apixaban	102	25
Ozempic	Semaglutide	96	15
Spironolactone	Spironolactone	93	27
Alprazolam	Alprazolam	92	15
Montelukast Sodium	Montelukast Sodium	91	30
Clopidogrel	Clopidogrel Bisulfate	82	26
Metformin Hcl Er	Metformin Hcl	81	26
Hydralazine Hcl	Hydralazine Hcl	79	19
Synthroid	Levothyroxine Sodium	75	19
Rosuvastatin Calcium	Rosuvastatin Calcium	71	25
Tamsulosin Hcl	Tamsulosin Hcl	71	27
Carvedilol	Carvedilol	68	21
Tizanidine Hcl	Tizanidine Hcl	68	28
Pravastatin Sodium	Pravastatin Sodium	66	22
Fluoxetine Hcl	Fluoxetine Hcl	65	14
Venlafaxine Hcl Er	Venlafaxine Hcl	65	18
Duloxetine Hcl	Duloxetine Hcl	62	20
Citalopram Hbr	Citalopram Hydrobromide	61	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	60	18
Celecoxib	Celecoxib	59	11
Meloxicam	Meloxicam	58	23
Enalapril Maleate	Enalapril Maleate	54	11
Doxycycline Hyclate	Doxycycline Hyclate	53	45
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	53	22
Potassium Chloride	Potassium Chloride	53	15
Finasteride	Finasteride	52	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	52	13
Atenolol	Atenolol	51	16
Bupropion Xl	Bupropion Hcl	51	14
Valsartan	Valsartan	51	15
Chlorthalidone	Chlorthalidone	50	11
Escitalopram Oxalate	Escitalopram Oxalate	49	14
Warfarin Sodium	Warfarin Sodium	47	13
Allopurinol	Allopurinol	46	13
Fenofibrate	Fenofibrate	46	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	15
Cephalexin	Cephalexin	45	41
Ramipril	Ramipril	44	12
Fluticasone Propionate	Fluticasone Propionate	43	22
Ibandronate Sodium	Ibandronate Sodium	43	suppressed
Clonazepam	Clonazepam	41	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	39	suppressed
Januvia	Sitagliptin Phosphate	39	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	39	11
Esomeprazole Magnesium	Esomeprazole Magnesium	38	11
Ezetimibe	Ezetimibe	35	11
Pregabalin	Pregabalin	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Clonidine Hcl	Clonidine Hcl	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Buspirone Hcl	Buspirone Hcl	32	11
Mounjaro	Tirzepatide	32	suppressed
Propranolol Hcl Er	Propranolol Hcl	32	suppressed
Doxepin Hcl	Doxepin Hcl	30	suppressed
Methylprednisolone	Methylprednisolone	30	24
Cefdinir	Cefdinir	29	29
Valacyclovir	Valacyclovir Hcl	27	suppressed
Verapamil Er	Verapamil Hcl	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Eszopiclone	Eszopiclone	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	21
Triamcinolone Acetonide	Triamcinolone Acetonide	23	20
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Etodolac	Etodolac	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	21	suppressed
Spiriva Handihaler	Tiotropium Bromide	21	suppressed
Diazepam	Diazepam	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Jardiance	Empagliflozin	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Prednisone	Prednisone	17	13
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Colestipol Hcl	Colestipol Hcl	16	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Metronidazole	Metronidazole	14	11
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Fluconazole	Fluconazole	13	11
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Nystatin	Nystatin	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error